Dendritic cell subpopulations in nasopharyngeal cancer.

C-lectin receptor antigen presentation langerin pattern recognition receptor

Journal

Oncology letters
ISSN: 1792-1074
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 30 04 2018
accepted: 17 09 2018
entrez: 6 2 2019
pubmed: 6 2 2019
medline: 6 2 2019
Statut: ppublish

Résumé

Nasopharyngeal cancer (NPC) is associated with Epstein-Barr virus (EBV) and EBV antigen may be utilized for therapeutic purposes, including targeting of dendritic cells (DCs). Although DCs may be present in NPC, the information is limited and not up-to-date with current knowledge on DC subsets. In the present study, biopsies from untreated NPC were obtained and subjected to multicolor flow-cytometry focusing on DC subtype markers: CD123 for plasmacytoid DCs (pDCs); and CD1c and CD141 for myeloid DCs (mDCs). Furthermore, subset-specific expression of the C-lectin receptor (CLR) CD207 (also termed langerin) was assessed. pDCs and mDCs were detected in the NPC lesions, contributing to a frequency mean average of 0.78% of CD45

Identifiants

pubmed: 30719121
doi: 10.3892/ol.2018.9835
pii: OL-0-0-9835
pmc: PMC6350184
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2557-2561

Références

Immunity. 2000 Jan;12(1):71-81
pubmed: 10661407
Int J Cancer. 2001 Oct 1;94(1):73-80
pubmed: 11668481
Cancer Res. 2002 Dec 1;62(23):6952-8
pubmed: 12460912
Acta Oncol. 2003;42(5-6):443-61
pubmed: 14596506
Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1107-16
pubmed: 15752890
J Clin Oncol. 2005 Dec 10;23(35):8942-9
pubmed: 16204009
BMC Cancer. 2007 May 24;7:88
pubmed: 17524139
J Immunol. 2008 Mar 15;180(6):3647-50
pubmed: 18322168
Head Neck Pathol. 2007 Sep;1(1):81-6
pubmed: 20614287
Int J Cancer. 2011 May 15;128(10):2501-8
pubmed: 20715107
Cancer Res. 2012 Mar 1;72(5):1116-25
pubmed: 22282657
Nat Rev Immunol. 2012 Jul 13;12(8):557-69
pubmed: 22790179
J Exp Med. 2013 May 6;210(5):1035-47
pubmed: 23569327
Immunology. 2014 Jun;142(2):279-88
pubmed: 24444310
Lancet. 2016 Mar 5;387(10022):1012-1024
pubmed: 26321262
Cancer Cell Microenviron. 2016;3(4):
pubmed: 28133621
Science. 2017 Apr 21;356(6335):
pubmed: 28428369
Sci Rep. 2018 May 23;8(1):8030
pubmed: 29795118
Hum Pathol. 1986 Sep;17(9):894-905
pubmed: 3759074
Int J Cancer. 1984 Jun 15;33(6):813-9
pubmed: 6329970
J Clin Pathol. 1984 Nov;37(11):1235-8
pubmed: 6389603
Jpn J Cancer Res. 1993 Aug;84(8):900-5
pubmed: 8407554
In Vivo. 1995 May-Jun;9(3):225-9
pubmed: 8562888

Auteurs

Johan S Nilsson (JS)

Department of Otorhinolaryngology, Head and Neck Surgery, Skåne University Hospital, Lund SE-221 85, Sweden.
Department of Clinical Sciences, Lund University, Lund SE-221 00, Sweden.

Milad Abolhalaj (M)

Department of Immunotechnology, Lund University, Lund SE-221 00, Sweden.

Kristina Lundberg (K)

Department of Immunotechnology, Lund University, Lund SE-221 00, Sweden.

Malin Lindstedt (M)

Department of Immunotechnology, Lund University, Lund SE-221 00, Sweden.

Lennart Greiff (L)

Department of Otorhinolaryngology, Head and Neck Surgery, Skåne University Hospital, Lund SE-221 85, Sweden.
Department of Clinical Sciences, Lund University, Lund SE-221 00, Sweden.

Classifications MeSH